Incident · 8-K Item 7.01; Item 1.05
The Oncology Institute reports patient data exposure through a software vendor
Compiled from public records. Updated 2026-11-07. By the cisonews.net Desk.
The Oncology Institute, Inc. disclosed to the SEC in a Form 8-K dated May 22, 2026 that a software vendor detected unauthorized access by a third party to certain information systems, including systems affecting data of patients. The filing gives no patient count and does not list the types of information involved.
Entries like this one, in Wednesday’s docket
Wednesdays
Unsubscribe any time.
What happened and when
The company first addressed the matter in an Item 7.01 filing dated November 6, 2025. It said it determined on November 3, 2025 that a cybersecurity incident at an information technology software provider would potentially delay fee-for-service collections.
At that point the provider had not indicated that patient information was compromised, and an investigation was ongoing.
On May 20, 2026, Kroll, described as the third-party administrator for the vendor, notified the company of the unauthorized access.
What the documents say about the data
The filings do not name the categories of patient information involved, so no list can be given here. The company says it believes the incident affected various other healthcare service providers.
The vendor has set up a patient portal for information and responses to inquiries.
The company says it will work with the vendor to offer credit monitoring and protection to all impacted patients. The filing does not state an enrollment deadline.
Effect on operations and finances
In November 2025 the company expected only a brief, immaterial delay in collecting some claims in its fee-for-service segment.
In May 2026 it said operations had continued in all material respects since the incident was detected.
The company also said it believed the incident had not had a material impact on operations, financial systems or quality of care. It was still evaluating any other material impact, including on financial condition or results of operations.
The company reserved all rights regarding potential claims against relevant third parties or service providers.
What the 10-K said before the May filing, and the new name
The company's annual report for 2025, filed on March 12, 2026, said the incident caused a brief, immaterial delay in collecting some claims. At that point the software provider had not reported any evidence that patient personal information was compromised. That changed on May 20, 2026, when the vendor's administrator told the company of unauthorized access to systems affecting patient data, which led to the May 22 Item 1.05 filing.
On July 28, 2026, the company changed its name from The Oncology Institute, Inc. to Starling Oncology, Inc. Filings after that date, including any later update on this incident, appear under the new name on EDGAR.
| Date | Filing | What it said about the incident |
|---|---|---|
| November 6, 2025 | 8-K, Item 7.01 | Vendor incident; only a brief, immaterial delay in some collections expected |
| March 12, 2026 | 10-K for 2025 | Brief immaterial collection delay; no evidence of patient data compromise reported by the vendor |
| May 22, 2026 | 8-K, Item 1.05 | Vendor's administrator reports unauthorized access to systems affecting patient data |
| July 28, 2026 | 8-K, Item 5.03 | Company renamed Starling Oncology, Inc. |
Is The Oncology Institute the same company as Starling Oncology?
Yes. The company changed its name to Starling Oncology, Inc. on July 28, 2026, per its Item 5.03 filing.
Was patient data affected?
The May 22, 2026 filing says the vendor detected unauthorized access to certain company information systems, including systems affecting patient data. It gives no count and no data types.
What the documents leave open
None of the filings names the software vendor, states how many patients were affected, or lists the data types involved. The May 2026 filing says the company's investigation and assessment remain ongoing.
The rule behind an Item 1.05 filing
Form 8-K Item 1.05 is where a public company reports a cybersecurity incident it has determined to be material. Under the rule the SEC adopted on July 26, 2023, the filing is generally due four business days after the company determines that the incident is material. Source: U.S. Securities and Exchange Commission, press release 2023-139. The guide What is SEC Form 8-K Item 1.05, and what counts as a disclosed cyber incident? reads the rule in full, and the glossary defines Form 8-K Item 1.05.
Other health care incidents on cisonews.net
- MPOWERHealth Holdings LLC, Breach notice, first disclosed November 13, 2026
- Acadia Healthcare Company, Inc., Breach notice, first disclosed November 13, 2026
- Telecare Health, Breach notice, first disclosed November 9, 2026
- Sharecare Health Data Services, LLC, Breach notice, first disclosed November 6, 2026
- Nephrology Associates, P.C., Breach notice, first disclosed November 6, 2026
Sources
- 2025-11-06 · AThe Oncology Institute, Inc., Form 8-K, Item 7.01 (SEC EDGAR), published November 6, 2025
- 2026-05-22 · AThe Oncology Institute, Inc., Form 8-K, Item 1.05 (SEC EDGAR), published May 22, 2026
- 2026-03-12 · AThe Oncology Institute, Inc., Form 10-K for the year ended December 31, 2025 (SEC EDGAR), published March 12, 2026
- 2026-08-03 · AThe Oncology Institute, Inc., Form 8-K (Item 5.03), July 28, 2026 (SEC EDGAR), published August 3, 2026
- 2023-07-26 · AU.S. Securities and Exchange Commission, press release 2023-139, published July 26, 2023
Tier A: the organization itself (including notices it filed with a state attorney general), a regulator or SEC EDGAR. Tier B: established press. Each fact on this page carries its supporting passage in the page source.
Entries like this one, in Wednesday’s docket
Wednesdays
Unsubscribe any time.